ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 81 filers reported holding ADURO BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $659,000 | +86.7% | 558,531 | +67.8% | 0.02% | +125.0% |
| Q3 2019 | $353,000 | -51.6% | 332,929 | -29.7% | 0.01% | -50.0% |
| Q2 2019 | $729,000 | -53.9% | 473,318 | +19.0% | 0.02% | -54.3% |
| Q1 2019 | $1,583,000 | +1253.0% | 397,816 | +796.8% | 0.04% | +1066.7% |
| Q4 2018 | $117,000 | -96.4% | 44,361 | -84.5% | 0.00% | -97.2% |
| Q2 2016 | $3,245,000 | – | 286,936 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |